c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
about
Current advances in biomarkers for targeted therapy in triple-negative breast cancerCirculating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic markerThe three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.C-kit and PDGFRA gene mutations in triple negative breast cancer.Linking signaling pathways to transcriptional programs in breast cancer.Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer.Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast.E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinomaExpression and Clinical Significance of Androgen Receptor in Triple-Negative Breast CancerPhase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.Triple-negative breast cancer: investigating potential molecular therapeutic target.Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer.Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer.Estrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancer.Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients.Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer.Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer.Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression.In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancerContributions of Thyroid Hormone to Cancer Metastasis
P2860
Q28074202-8615B51C-CA64-4A9B-B4A2-5A4BA6C43C6EQ33668173-74D7D4DB-E886-4057-BF72-0B211D4AEF81Q33889355-04DB1D72-EC76-4D31-9CFB-862CFD0EB675Q33903662-24C7333D-EDDD-4EF7-830F-E12562E7DD00Q34029247-1DD53012-D4BF-4B8B-AE00-ECC2616E8ACDQ34439395-B72CDC62-3C67-4DF6-9716-2A9523903796Q36473017-38ED4C21-BA7E-4BF0-B6D9-C23072D866D5Q36854062-6D601EBF-C3A8-4C49-9BFD-4F4C6EB4F606Q37428209-000999AD-33D3-432A-B4E2-8A5B1828E8CDQ37567838-6E442181-A438-4547-A3CB-DF6840701732Q37629540-3BBF4D2C-73C7-4BD5-AE4C-E19955A02E70Q37635256-8A4FBF7F-07AF-4A68-B8B2-73AD4C528D6DQ38259322-32E91452-B484-4D0B-806F-61C780E07228Q41588399-091B400D-790C-48EB-98B7-46C61C57F435Q42364077-0D6747CF-F819-468B-A7F3-17EC74B9599AQ45073978-DC03FD82-C6C0-4F8C-A578-FCFE1775560FQ47863345-F06B55D9-C5AE-4CAD-A8CF-000D955ED833Q50331415-B2FA37A1-CCEE-4948-AC61-8AA1EBD4ED6AQ52609428-CFBB9C37-47A5-4004-8DEE-DF744166AB96Q55008104-DEEA0C99-C622-4DEA-9F10-BDFC802A1B8AQ55362114-B8E6AADD-FF6A-4A10-877D-37C19338C6A0Q58695321-B91196A9-9C9F-4576-8A27-99B506EA1BCBQ58717087-D94E5C24-C262-4C0E-B398-E24DA9584178
P2860
c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
c-Kit expression as a prognost ...... with basal-like breast cancer.
@en
c-Kit expression as a prognost ...... with basal-like breast cancer.
@nl
type
label
c-Kit expression as a prognost ...... with basal-like breast cancer.
@en
c-Kit expression as a prognost ...... with basal-like breast cancer.
@nl
prefLabel
c-Kit expression as a prognost ...... with basal-like breast cancer.
@en
c-Kit expression as a prognost ...... with basal-like breast cancer.
@nl
P2093
P2860
P356
P1476
c-Kit expression as a prognost ...... with basal-like breast cancer.
@en
P2093
H Kawajiri
K Hirakawa
S Kashiwagi
T Ishikawa
T Takashima
P2860
P304
P356
10.1002/BJS.9021
P407
P577
2013-01-14T00:00:00Z